Education

Medical School
Baylor College of Medicine (1996)
Residency
Baylor College of Medicine (1999), Internal Medicine
Fellowship
UT Southwestern Medical Center (2002), Infectious Diseases
Graduate School
University of Texas Health Science Center at Dallas (2004), Public Health

Research Interest

  • Hepatitis B
  • Hepatitis C
  • HIV and complications
  • HIV and Liver Disease
  • Influenza
  • Viral Eradication

Publications

Featured Publications LegendFeatured Publications

Evaluation of a multifaceted intervention to reduce health disparities in hepatitis C screening: a pre-post analysis.
Jain MK, Rich NE, Ahn C, Turner BJ, Sanders JM, Adamson B, Quirk L, Perryman P, Santini NO, Singal AG, Hepatology 2019 Apr
Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data.
Nijhawan AE, Metsch LR, Zhang S, Feaster DJ, Gooden L, Jain MK, Walker R, Huffaker S, Mugavero MJ, Jacobs P, Armstrong WS, Daar ES, Sullivan M, Del Rio C, Halm EA J. Acquir. Immune Defic. Syndr. 2019 Mar 80 3 330-341
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.
Pinato DJ, Allara E, Chen TY, Trevisani F, Minguez B, Zoli M, Harris M, Dalla Pria A, Merchante N, Platt H, Jain M, Caturelli E, Kikuchi L, Pineda J, Nelson M, Farinati F, Rapaccini GL, Aytaman A, Yin M, Tan CK, Bower M, Giannini EG, Bräu N J. Clin. Oncol. 2019 Feb 37 4 296-304
Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups.
Turner BJ, Wang CP, Melhado TV, Bobadilla R, Jain MK, Singal AG Clin. Gastroenterol. Hepatol. 2018 Dec
Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.
Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG Am. J. Gastroenterol. 2018 Nov
Has Access to HCV Therapy Changed for Patients with Mental Health or Substance Use Disorders in the DAA Period?
Jain MK, Thamer M, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Wong RJ Hepatology 2018 Jul
Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.
Wong RJ, Jain MK, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Thamer M Am. J. Gastroenterol. 2018 Mar
Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
Whitmill A, Kim S, Rojas V, Gulraiz F, Afreen K, Jain M, Singh M, Park IW PLoS ONE 2018 13 8 e0202524
Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study.
Yek C, de la Flor C, Marshall J, Zoellner C, Thompson G, Quirk L, Mayorga C, Turner BJ, Singal AG, Jain MK BMC Med 2017 Nov 15 1 204

Honors & Awards

  • Fellow of Infectious Disease Society of America
    (2015)
  • Best Doctors in Dallas "D Magazine"
    (2011)
  • K23 NIH Grant
    (2005)
  • Student Research Grant
    (2003)
  • Training Award
    Patient Oriented Research (2001)
  • Travel Grant Award
    Outstanding Abstract Submission, IDSA (2001)

Professional Associations/Affiliations

  • Texas Infectious Disease Society (2018)
  • Infectious Disease Society of America, Fellow (2015)
  • American Association for the Study of Liver Disease (2003)
  • Infectious Disease Society of America (2002)